Lauren Hitt
Family · Gulfport, MSNPI 1053760850
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,451 of the $4,549 with a category attached, or 75.9%. 38 manufacturers reported payments, led by Novartis at 27.5% of the total. Reporting peaked in 2021 at $3,707 and has fallen 95.5% since, to $167 in 2023. Among family clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 204 payments — averaging $22.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$1K
- Incyte Corporation$288
- Amgen$276
- Exelixis Inc.$264
- Merck$241
- Beigene USA, Inc.$205
- plus $2K from 32 others
What the payments were for
- Food & beverage$3,45176%
- Other$1,09824%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 20 | $1,251 |
| Incyte Corporation | 11 | $288 |
| Amgen | 15 | $276 |
| Exelixis Inc. | 11 | $264 |
| Merck | 14 | $241 |
| Beigene USA, Inc. | 7 | $205 |
| Daiichi Sankyo Inc. | 12 | $173 |
| AstraZeneca(2 entities) | 10 | $170 |
| Johnson & Johnson(2 entities) | 10 | $157 |
| Eisai Inc. | 9 | $144 |
| Seagen Inc. | 8 | $127 |
| Ipsen Biopharmaceuticals, Inc | 6 | $118 |
| Bayer | 6 | $111 |
| Lilly USA, LLC | 6 | $97 |
| EMD Serono, Inc. | 5 | $82 |
| E.r. Squibb & Sons, L.L.C. | 6 | $80 |
| Genentech USA, Inc. | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $66 |
| Acceleron Pharma, Inc. | 4 | $66 |
| Puma Biotechnology, Inc. | 5 | $66 |
| Sanofi | 4 | $64 |
| Pfizer | 4 | $62 |
| Karyopharm Therapeutics Inc. | 2 | $35 |
| Myovant Sciences Inc. | 2 | $35 |
| Rigel Pharmaceuticals, Inc. | 2 | $33 |
| AbbVie | 2 | $32 |
| Blueprint Medicines Corporation | 2 | $29 |
| Kyowa Kirin, Inc. | 2 | $29 |
| Boston Scientific | 1 | $29 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $26 |
| Bristol Myers Squibb | 1 | $24 |
| Coherus Oncology, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Emmaus Medical, Inc. | 1 | $17 |
| Dova Pharmaceuticals | 1 | $16 |
| Array Biopharma Inc | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
| Morphosys, US Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,549 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.
Other family in Gulfport
- Stephanie RomeroGulfport$28K
- Ashley HouseGulfport$14K
- Chaeleena LaddGulfport$14K
- Justine HuntGulfport$12K
- Laura StevensGulfport$11K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.